Jesse E. Hanson
Genentech · 69 works · 5,957 citations · h-index 32
Top works
- Microglia in Alzheimer’s disease
- Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
- Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy
- Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models
- Disease-associated oligodendrocyte responses across neurodegenerative diseases
- PresynapticFmr1Genotype Influences the Degree of Synaptic Connectivity in a Mosaic Mouse Model of Fragile X Syndrome
- Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
- SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
- Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration
- The functional nature of synaptic circuitry is altered in area CA3 of the hippocampus in a mouse model of Down's syndrome
- GABAB and group I metabotropic glutamate receptors in the striatopallidal complex in primates
- Short-Term Plasticity Shapes the Response to Simulated Normal and Parkinsonian Input Patterns in the Globus Pallidus
- Group I Metabotropic Glutamate Receptors at GABAergic Synapses in Monkeys
- Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design
- Dynamin-dependent NMDAR endocytosis during LTD and its dependence on synaptic state
- Sodium Channels and Dendritic Spike Initiation at Excitatory Synapses in Globus Pallidus Neurons
- The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration
- Targeting synapse function and loss for treatment of neurodegenerative diseases
- Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia
- Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry